US FDA grants accelerated approval to CTI BioPharma's Vonjo to treat myelofibrosis and thrombocytopenia

Press/Media

Period2 Mar 2022

Media coverage

1

Media coverage

  • TitleUS FDA grants accelerated approval to CTI BioPharma's Vonjo to treat myelofibrosis and thrombocytopenia
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date2/03/22
    PersonsJohn Mascarenhas
View all 1
View less